Prof. Chi-Chiang Yang

Chung Shan Medical University, Chinese Taipei

Email: wangyuedan@hotmail.com

Qualifications

1994  Ph.D., Department of Microbiology, Chinese Taipei

1987  B.Sc., Chung Shan Medical College, Chinese Taipei

Publications (Selected)

1. Ho CC, Lin SS, Chou MY, Chen FL, Hu CC, Chen CS,Lu GY, Yang CC*.Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J AntimicrobChemoth 2005;56: 372-379.
2. Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC*.Association of viral factor with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005;75:276-281.
3. Lin SJ, Tsai JH, Tsai CH, Lin YC, Hsu HT,Xu FL,Yang CC*.The in vivoeffects of cytokine modulation for Balb/C micegiven Canavaliaensiformis(L.) seeds with different heat treatment. Food Chem 2005;91:139-145.
4. Wang L, Lin SJ, Tsai JH, Tsai CH, Tsai CC, Yang CC*. Anti-HBs IgG1 subclass is predominant in individuals who have recovered from HBV infection, chronic carriers and in vaccinees.Med MicrobiolImmunol 2005; 194:33-38.
5. Lai HC, Lin SJ, Lin HR, Ku CS, Yang CC*.Phylogenetic analyses of human rotavirusin central Taiwan in 1996, 2001 and 2002. J ClinVirol 2005;32:199-217.
6. LinSS, Chou MY, Ho CC, Kao CT, Tsai CH, Wang L, Yang CC*. Study of the viral infections and cytokinesassociated with recurrent aphthous ulceration. Microb Infect 2005;7:635-644.
7. Yang YY, Huang CF, Wei JCC, Ho MS, Wang L, Lin SJ,Tsai WY, Lin CC, Xu FL, YangCC*.The study of IgG subclass profiles of anti-HBcin populations with different status of HBV infection. Cell MolImmunol 2005, 2;393-398.
8. Lin SJ, Chen CS,Ho CC, Lin SS, Shih HT, Lee IP, Chou MY, Kao CT,Chen FL, Ho YC, Hsieh KH, Huang CR,Yang CC*.In vitro anti-microbial and in vivo cytokines modulation effects of different prepared Chinese herbal medicines.Food ChemToxicol. 2006, 44;2078-2085.
9. Tsai TH, Huang CF, Wei JCC, Ho MS, Wang L, Tsai WY, Lin CC, Xu FL, Yang CC*. The study of IgG subclass profiles of anti-HBs in populations with different status of HBV infection.Viral Immunol 2006, 19; 277-284.
10. Huang CF, Lin SS, Ho YC, Chen FL, Yang CC*.The immune response induced by hepatitis B virus principal antigens. Cell MolImmunol 2006,3: 97-106.
11. Xu FL, Yang ZQ, Wang L, Lee YL, Yang CC*, Xiao SY, Xiao H, Wen L. Morphological characterization ofhantavirus HV114: Hypothesis for morphogenesis. Intervirology 2007, 50; 166-172.
12. Wang L,Tsai TH, Huang CF, Ho MS, Lin DB, Ho YC, Lin SS, Wei JCC,Chou MC, Yang CC*. Utilizing self-preparedELISA plates for a cross-population study of different anti-HBeIgGsubclassprofiles. JMed Virol 2007, 79, 495-502.
13. Tsai JH, Hsu CS, Tsai CH, Su JM, Liu YT,Cheng MH, Wei JCC,Chen FL, Yang CC*.Relationship between viral factors, axillary lymph-node status andsurvival inbreast cancer.J Cancer Res ClinOncol 2007, 133;13-21.
14. Lin SS, Liao PH, Young SC, Yang CC*.The immunopharmaceutical effects and mechanisms of herb medicine. Cell MolImmunol, 2008, 5, 23-31.
15. Tsai HT, Lu TM, Tsai TH,Yang CC*. Immunopathology of hepatitis B virus infection.Int RevImmunol 2008,27, 427-446.
16. Lin SS, Xu F, Liao PH, Yang CC*.Recent progress in the development of inhibitors of human imunodeficiency virus (HIV) integrase for the management of HIV infection.ActaVirol2008, 52, 197-207.
17. Cheng MH, Cheng HT, Lin SS, Young SC, Pai CJ, Liao PH, Chen SC, Chou MY, Yang JJ, Yang CC*.Apoptotic characteristics of MMC-treated HeLa cells and cellular localization and characteristics of induced P-glycoprotein 170. Drug ChemToxicol 2009, 32,158-168.
18. Wu JL, Lin YJ, Yang CC, Wu SF, Lin YT, Lin YS, Huang CF. MCRS2 represses the transactivation activities of Nrf1. BMC Cell Biology 2009, 10: 9.
19. Hsu CR, Lu TM, ChinLW, Yang CC*. Possible DNA viral factors of human breast cancer. Cancers 2010, 2(2), 498-512.
20. Hsueh CW, Lin SS, Lin CH, Chien ST, Lin FG, Tsai HT, Huang CF, Yang CC*. Diagnosis and mutation assays of drug resistance related to rifampicin and isoniazid of clinical Mycobacterium tuberculosis isolates in Taiwan.Ann Microbiology 2010,60, 391-397.
21. TsaiWC,Rao YK, LinSS, Chou MY, Shen YT, Wu CH, GeethangiliM, Yang CC*, Tzeng YM*.Methylantcinate A induces tumor specific growth inhibition in oral cancer cells via Bax-mediatedmitochondrial apoptotic pathway.Bioorg Med Chem Lett 2010, 20, 6145-6148.
22. ChinLW, Cheng YW, Lin SS, Lai YY, Lin LY, Chou MY, Chou MC, Yang CC*. Anti-herpes simplex virus effects of berberine from Coptidisrhizome, a major component of a Chinese herbal medicine, Ching-Wei-San.Arch Virol 2010,155(12), 1933-1941.